Cargando…
Step-Counting Accuracy of a Commercial Smartwatch in Mild-to-Moderate PD Patients and Effect of Spatiotemporal Gait Parameters, Laterality of Symptoms, Pharmacological State, and Clinical Variables
Commercial smartwatches could be useful for step counting and monitoring ambulatory activity. However, in Parkinson’s disease (PD) patients, an altered gait, pharmacological condition, and symptoms lateralization may affect their accuracy and potential usefulness in research and clinical routine. St...
Autores principales: | Bianchini, Edoardo, Caliò, Bianca, Alborghetti, Marika, Rinaldi, Domiziana, Hansen, Clint, Vuillerme, Nicolas, Maetzler, Walter, Pontieri, Francesco E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823757/ https://www.ncbi.nlm.nih.gov/pubmed/36616812 http://dx.doi.org/10.3390/s23010214 |
Ejemplares similares
-
Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
por: Bianchini, Edoardo, et al.
Publicado: (2023) -
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study
por: De Carolis, Lanfranco, et al.
Publicado: (2023) -
Monoamine-oxidase Type B Inhibitors and Cognitive Functions in Parkinson’s Disease: Beyond the Primary Mechanism of Action
por: Rinaldi, Domiziana, et al.
Publicado: (2023) -
Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings
por: Alborghetti, Marika, et al.
Publicado: (2023) -
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
por: Bianchini, Edoardo, et al.
Publicado: (2022)